Kirtland Hills Capital Management’s Astera Labs ALAB Stock Holding History

Kirtland Hills Capital Management’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$637K	Buy	+1,318	New	+$350K	0.18%	111

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Kirtland Hills Capital Management's ALAB Position: Q2 2026 in Review

Kirtland Hills Capital Management opened a new position in Astera Labs (ALAB) in Q2 2026: 1,318 shares worth $637K. The stake represents 0.18% of the portfolio and ranks #111 among its holdings.

981 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Kirtland Hills Capital Management held 1,318 shares of Astera Labs worth $637K as of Q2 2026.
Astera Labs was a new Kirtland Hills Capital Management position in Q2 2026.
Astera Labs made up 0.18% of Kirtland Hills Capital Management's portfolio in Q2 2026, its #111 holding.
981 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Kirtland Hills Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.